Megasoft Limited (NSE:MEGASOFT)
India · Delayed Price · Currency is INR 114.48
-6.03 (-5.00%)
Aug 13, 2025, 3:29 PM IST
Checkpoint Therapeutics Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
Operating Revenue | -63.6 | - | - | 19.71 | 523.96 | 594.02 | Upgrade |
Other Revenue | 1,846 | - | - | - | - | - | Upgrade |
| 1,783 | - | - | 19.71 | 523.96 | 594.02 | Upgrade | |
Revenue Growth (YoY) | - | - | - | -96.24% | -11.79% | 4.71% | Upgrade |
Cost of Revenue | - | - | 1.99 | 4.56 | 180.59 | 201.29 | Upgrade |
Gross Profit | 1,783 | - | -1.99 | 15.15 | 343.38 | 392.73 | Upgrade |
Selling, General & Admin | 28.68 | 26.13 | 21.66 | 41.52 | 238.73 | 216.54 | Upgrade |
Other Operating Expenses | 216.94 | 78.21 | 65.55 | 129.64 | 139.46 | 122.12 | Upgrade |
Operating Expenses | 288.43 | 149 | 119.1 | 220.37 | 544.46 | 384.94 | Upgrade |
Operating Income | 1,494 | -149 | -121.09 | -205.22 | -201.08 | 7.79 | Upgrade |
Interest Expense | -174.18 | -182.15 | -169.27 | -100.63 | -21.33 | -46.03 | Upgrade |
Interest & Investment Income | - | - | 0.13 | - | 1.2 | 1.75 | Upgrade |
Earnings From Equity Investments | -210.86 | -383.85 | -203.32 | -25.44 | - | - | Upgrade |
Currency Exchange Gain (Loss) | - | - | -0.02 | -0.2 | -1.52 | -3.08 | Upgrade |
Other Non Operating Income (Expenses) | 431.38 | 415.63 | 372.46 | 410.28 | 217.29 | 58.02 | Upgrade |
EBT Excluding Unusual Items | 1,541 | -299.37 | -121.1 | 78.8 | -5.44 | 18.46 | Upgrade |
Asset Writedown | - | - | - | - | -16.74 | - | Upgrade |
Other Unusual Items | - | - | - | 9.49 | 74.59 | - | Upgrade |
Pretax Income | 1,541 | -299.37 | -121.1 | 88.29 | 52.42 | 18.46 | Upgrade |
Income Tax Expense | 310 | - | 6.36 | - | 6.21 | -0.03 | Upgrade |
Net Income | 1,231 | -299.37 | -127.47 | 88.29 | 46.21 | 18.48 | Upgrade |
Net Income to Common | 1,231 | -299.37 | -127.47 | 88.29 | 46.21 | 18.48 | Upgrade |
Net Income Growth | - | - | - | 91.06% | 150.06% | 161.36% | Upgrade |
Shares Outstanding (Basic) | 74 | 74 | 74 | 74 | 63 | 44 | Upgrade |
Shares Outstanding (Diluted) | 74 | 74 | 74 | 74 | 63 | 44 | Upgrade |
Shares Change (YoY) | 1.65% | -0.04% | - | 17.36% | 42.00% | - | Upgrade |
EPS (Basic) | 16.70 | -4.06 | -1.73 | 1.20 | 0.74 | 0.42 | Upgrade |
EPS (Diluted) | 16.70 | -4.06 | -1.73 | 1.20 | 0.74 | 0.42 | Upgrade |
EPS Growth | - | - | - | 62.80% | 76.10% | 161.36% | Upgrade |
Free Cash Flow | - | 194.75 | 305.32 | 136.85 | 153.23 | 165.3 | Upgrade |
Free Cash Flow Per Share | - | 2.64 | 4.14 | 1.85 | 2.44 | 3.73 | Upgrade |
Gross Margin | 100.00% | - | - | 76.85% | 65.53% | 66.11% | Upgrade |
Operating Margin | 83.82% | - | - | -1041.21% | -38.38% | 1.31% | Upgrade |
Profit Margin | 69.03% | - | - | 447.96% | 8.82% | 3.11% | Upgrade |
Free Cash Flow Margin | - | - | - | 694.31% | 29.24% | 27.83% | Upgrade |
EBITDA | 1,543 | -104.34 | -94.11 | -176.82 | -176.38 | 31.16 | Upgrade |
EBITDA Margin | 86.57% | - | - | - | -33.66% | 5.24% | Upgrade |
D&A For EBITDA | 49.08 | 44.66 | 26.98 | 28.41 | 24.7 | 23.37 | Upgrade |
EBIT | 1,494 | -149 | -121.09 | -205.22 | -201.08 | 7.79 | Upgrade |
EBIT Margin | 83.82% | - | - | - | -38.38% | 1.31% | Upgrade |
Effective Tax Rate | 20.12% | - | - | - | 11.84% | - | Upgrade |
Revenue as Reported | 415.63 | 415.63 | 373.95 | 438.33 | 790.98 | 662.66 | Upgrade |
Advertising Expenses | - | - | 0.24 | 1.7 | 77.36 | 79.9 | Upgrade |
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.